8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 18, 2000 NMT Medical, Inc. -------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware 000-21001 95-4090463 -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer diction of incorporation) File Number) Identification No.) 27 Wormwood Street, Boston, Massachusetts 02210 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (617) 737-0930 N/A -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events. ------------ On July 18, 2000, NMT Medical, Inc. (the "Company") issued a press release announcing that the Board of Directors of the Company has restructured the interim management team so as to allow the Office of the President to have more of the day-to-day operating responsibilities. Accordingly, Jeffrey R. Jay, M.D., the Chairman of the Board, and R. John Fletcher, a member of the Board, have each resigned as Acting Co-Chief Executive Officer. William J. Knight, Vice President of Finance and Administration and Chief Financial Officer, and Rudy Davis, Vice President of Sales and Marketing, will each continue to serve as Acting Co-President. The full text of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. ------------------------------------------------------------------ (c) Exhibits Exhibit No. Description ----------- ----------- 99.1 Press Release, dated July 18, 2000, announcing the restructuring of the interim management team of NMT Medical, Inc. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 19, 2000 NMT Medical, Inc. ----------------- (Registrant) By: /s/ Randall W. Davis ----------------------------- Name: Randall W. Davis Title: Acting Co-President -3- EXHIBIT INDEX Exhibit No. Description ----------- ----------- 99.1 Press Release, dated July 18, 2000, announcing the restructuring of the interim management team of NMT Medical, Inc.